-T/NK:

Dae-Ho Choi1, Sang Eun Yoon2, Junhun Cho3

  • 1Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea, pearlnod1234@gmail.com.

Acta haematologica
|March 3, 2024
PubMed
概括

初级节点艾普斯坦-巴尔病毒阳性T细胞/NK细胞淋巴瘤 (PTCL-EBV) 是一种新分类的疾病. ICE/Dexa疗法在PTCL-EBV治疗方面表现有前途,而造血干细胞移植 (HSCT) 改善了整体存活率.